Page last updated: 2024-09-05

17-(3-pyridyl)androsta-5,16-dien-3-one and mdv 3100

17-(3-pyridyl)androsta-5,16-dien-3-one has been researched along with mdv 3100 in 1 studies

Compound Research Comparison

Studies
(17-(3-pyridyl)androsta-5,16-dien-3-one)
Trials
(17-(3-pyridyl)androsta-5,16-dien-3-one)
Recent Studies (post-2010)
(17-(3-pyridyl)androsta-5,16-dien-3-one)
Studies
(mdv 3100)
Trials
(mdv 3100)
Recent Studies (post-2010) (mdv 3100)
8061,5461821,502

Protein Interaction Comparison

ProteinTaxonomy17-(3-pyridyl)androsta-5,16-dien-3-one (IC50)mdv 3100 (IC50)
Gamma-aminobutyric acid receptor subunit piHomo sapiens (human)3
Gamma-aminobutyric acid receptor subunit deltaHomo sapiens (human)3
Prostate-specific antigenHomo sapiens (human)0.13
Androgen receptorHomo sapiens (human)0.8644
Gamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)3
Androgen receptorRattus norvegicus (Norway rat)0.8238
Gamma-aminobutyric acid receptor subunit beta-1Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)3
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)1.26
Gamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-5Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-2Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit beta-2Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-4Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit epsilonHomo sapiens (human)3
Gamma-aminobutyric acid receptor subunit alpha-6Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-1Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit gamma-3Homo sapiens (human)3
Gamma-aminobutyric acid receptor subunit thetaHomo sapiens (human)3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alyamani, M; Auchus, RJ; Bishop, AC; Bunch, D; Dreicer, R; Garcia, JA; Li, Z; Liu, J; Sharifi, N; Upadhyay, SK1

Other Studies

1 other study(ies) available for 17-(3-pyridyl)androsta-5,16-dien-3-one and mdv 3100

ArticleYear
Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.
    Nature, 2015, Jul-16, Volume: 523, Issue:7560

    Topics: 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Androgen Receptor Antagonists; Androgens; Androstenes; Animals; Benzamides; Biosynthetic Pathways; Biotransformation; Cell Division; Chromatin; Dihydrotestosterone; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Steroid 17-alpha-Hydroxylase; Survival Analysis; Xenograft Model Antitumor Assays

2015